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Acetone extracts of C. woodii leaf powder was separated by solvent-solvent partition into six fractions. 
The highest total activity was in the chloroform fraction. This fraction contained mainly one compound 
active against S. aureus. This compound was isolated by bioassay-guided fractionation using silica gel 
open column chromatography and identified by nuclear magnetic resonance (NMR) and mass 
spectroscopy (MS) as the stilbene 2’,3’,4-trihydroxyl-3,5,4’-trimethoxybibenzyl (combretastatin B5) 
previously isolated from the seeds of C. kraussii. It showed significant activity against S. aureus with 
an MIC of 16 µg/ml but with lower activity towards P. aeruginosa (125 µg/ml), E. faecalis (125 µg/ml) and 
slight activity against E. coli. This is the first report of the antimicrobial activity of combretastatin B5. 
Its concentration in the leaves was in the order of 5-10 mg/g which makes the use of non-polar leaf 
extracts a viable proposition in treating some infections, particularly in resource-poor settings. 
 





With the increasing resistance of bacteria to antibiotics 
due to misuse and over prescription, there is a need to 
develop new antibiotics to delay or prevent the arrival of a 
post-antibiotic era (Leggadrio, 1995).  Plants have been 
used for centuries to treat infectious diseases and 
present an obvious source of new antimicrobial 
compounds (Cowan, 1999).  Thus far, there has been 
little success in developing new compounds from plants 
for use in the pharmaceutical industry, but more success 
in developing plant extracts to be used especially to treat 
skin infections is likely. 
The Combretaceae is widely distributed in the tropical 
climes of Africa, South America and Asia (but not in 
Australia) and is an important resource in traditional 
medical practice. Species of the two main genera, 
Combretum and Terminalia have been used in the 
treatment of syphilis, abdominal pains, conjunctivitis, 
diarrhoea and toothache, among other ailments 
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Breyer-Brandwijk, 1962). Several species of Combretum 
have antibacterial activity (Eloff, 1999; Martini and Eloff, 
1998; Martini et al., 2004a). Several compounds including 
flavonoids, phenanthrenes, stilbenes, cyclobutanes and 
triterpenoids have been isolated (Pettit et al., 1987a, 
1987b, 1995; Rogers and Verotta, 1995; Katerere, 2001; 
Katerere et al., 2004; Martini et al., 2004b). 
In a preliminary screening of 27 members of the 
Combretaceae, acetone leaf extracts of C. woodii, a 
deciduous tree found in northern South Africa and 
Swaziland had a reasonable antibacterial activity (Eloff, 
1999). It contained antibacterial constituents that have 
different Rf values to the closely related species, C. 
erythrophyllum (unpublished results). More detailed 
investigation of C. woodii (Eloff et al., 2005) revealed that 
intermediate polarity extracts have substantial 
antibacterial activity against Staphylococcus aureus, 
Pseudomonas aeruginosa, Escherichia coli and 
Enterococcus faecalis with minimum inhibitory 
concentration (MIC) values in the order of 0.04 mg/ml. 
These activities were better than the two positive controls 
ampicillin and chloramphenicol. In many cases where 
antimicrobial compounds have been isolated, the 
compounds are present in low concentrations.  In the 
acetone    extracts    of   C.   woodii   one   of   the   major  
 




compounds was also the principal antibacterial 
compound against S. aureus. This compound also had a 
distinctive colour reaction with vanillin-sulphuric acid 
(Eloff et al., 2005) and it seemed appropriate to isolate 
and characterise it. 
We report here for the first time the isolation of a 
stilbene, the main antibacterial compound from the 
leaves of C. woodii. Although the compound has been 
previously isolated from the seeds of C. kraussi, this is 
the first report of its presence in high concentrations in 







Leaf material was collected from two trees growing in the Lowveld 
National Botanical Garden, Nelspruit, South Africa. The origin of 
each tree is recorded in the database of the botanical garden and a 




Analysis of extracts by TLC 
 
The following solvent systems were used to analyse fractions by 
thin layer chromatography (TLC) using Merck, Kieselgel 60 F254 
plates : benzene : ethanol : ammonium hydroxide (BEA) (36:4:0.4), 
ethylacetate : methanol : water (EMW) (40:5.4:4) and chloroform : 
ethylacetate : formic acid (CEF) (20:16:4). Separated compounds 
were visualized by spraying with freshly prepared vanillin spray 
reagent (0.1 g vanillin, 28 ml methanol, 1 ml sulphuric acid) (Stahl, 




Extraction and preliminary fractionation  
 
Dried leaves (150 g) were milled into a fine powder with a Jankel 
and Kunkel model A10 mill and then extracted with acetone to yield 
15.6 g. This was further fractionated using the solvent-solvent 
fractionation procedure recommended by the USA National Cancer 
Institute as described by Suffness and Douros (1979) and adapted 
by Eloff (1998a). This process leads to six fractions separated 
based on solubility characteristics of the constituents. 
All extracts were then taken to dryness in a vacuum rotatory 
evaporator and weighed. Extracts were reconstituted in appropriate 
solvent to make up stock solutions of 20 mg/ml. A 5 µl aliquot of 
each was loaded on TLC plates (Merck) that were developed using 





The number of antibacterial compounds present was determined by 
bioautography using the method described by Begue and Kline 
(1972).  The minimum inhibitory concentration (MIC) of fractions 
was determined by a serial dilution microplate assay using 
tetrazolium violet to indicate growth of the bacteria (Eloff, 1998b). 
Four organisms recommended by the National Committee for 
Clinical Laboratory Standards (NCCLS, 1992) as important 
causative agents of nosocomial infections were used. These were 
Staphylococcus aureus (ATCC 29213), Pseudomonas aeruginosa 





faecalis (ATCC21212). The MIC of the isolated compound was 
compared with reference antibiotics (ampicillin and chloram-
phenicol) as positive controls. 
 
 
Isolation by column chromatography 
 
About 4 g of the chloroform fraction, which had the highest total 
antibacterial activity, was applied to a Silica gel 60 (63-200 µm) 
(Merck) column and eluted with varying mixtures of chloroform and 
ethyl acetate. Eluted fractions were collected and allowed to 
concentrate under an air stream at room temperature and analysed 
by TLC and bioautography. Compound 1 was purified by 
recrystallization from a mixture of methanol and chloroform. 1H- and 
13C-NMR spectra were obtained at Medical University of Southern 
Africa (Medunsa) on a 300 MHz Varian NMR machine (Oxford 
instruments). Mass spectrometric analysis (HREIMS) was 
performed on a VG70-SEQ instrument at Cape Technikon. 
 
 
RESULTS AND DISCUSSION 
 
Acetone extracted about 10 % (15.60 g) of starting plant 
material. In the group separation technique, the quantity 
partitioning into the various solvents was determined. The 
highest percentage went into hexane (32%) and 
chloroform (26%). Water and 35% water in methanol had 
the lowest percentage (Figure 2). This was similar to the 
result obtained in a previous study on C. erythrophyllum 
(Martini and Eloff, 1998).  
We assayed the various fractions for antibacterial 
activity using bioautography (Figure 3) and the micro-titre 
assays described above. Most of the activity was in the 
chloroform and hexane fractions. These fractions showed 
the highest total activity, calculated by dividing the mass 
by the MIC value (Table 1) as suggested by Eloff (2000, 
2004), against the four test bacteria. The aim was to 
isolate the main antibacterial compound with an Rf of 
0.74 in EMW.  Inspection of the bioautogram (Figure 3) 
shows that this compound was present in five of the 
fractions. There were also at least six other antibacterial 
compounds. The chloroform fraction had a relatively 
simple composition containing predominantly the main 
antibacterial compound. This compound was yellow in 
visible light, fluoresced purple-blue in 365 nm light and 
was maroon turning to brown later after treating with 
vanillin-sulphuric acid spray reagent. Column 
chromatography of the chloroform fraction as described 
above led to the successful isolation of this compound 
(1).  
The structure of compound 1 (Figure 1) was elucidated 
by NMR and MS as the bibenzylic compound, 2’,3’,4-
trihydroxyl-3,5,4’-trimethoxyl bibenzyl (combretastatin B5) 
previously isolated from the seeds of C. krausii (Pellizzoni 
et al., 1992). HREI-MS gave a molecular ion at m/z 320 
corresponding to C17H20O6 and only two major fragments 
at m/z 153 (C8H9O3) and 167 (C9H11O3). This is typical of 
tropylium derivatives associated with bibenzylic com-
pounds (Letcher et al., 1972; Katerere, 2001). The 
fragmentation pattern was also suggestive of dihydroxy- 
 




Table 1. MIC in mg/ml and total activity in ml of acetone extract of C. woodii leaves in hexane, chloroform, carbon 
tetrachloride, 35% water in methanol, butanol and water fractions obtained by solvent-solvent fractionation towards 
four bacterial pathogens 
 
Bacteria H CHCl3 CCl4 35% W/M BuOH Water 
Total quantity obtained in mg 320 256 64 65 117 72 
MIC mg/ml 
S. aureus 0.6 0.3 0.1 0.2 0.2 > 5.0 
E. coli 2.5 2.5 5.0 5.0 5.0 > 5.0 
P. aeruginosa 0.3 0.3 0.3 2.5 2.5 5.0 
E. faecalis 0.6 0.1 0.2 0.1 0.6 0.6 
Total activity in ml 
S. aureus 533 853 640 325 585 <5 
E. coli 128 102 13 13 23 <5 
P. aeruginosa 1067 853 213 26 47 14 
E. faecalis 533 2560 320 650 195 120 
Total activity all organisms 2261 4360 1186 1014 850 134 
Distribution of mass and total antibacterial activity 
% of total mass 35.8 28.6 7.2 7.3 13.1 8.1 
% of total activity 23.1 44.5 12.1 10.3 8.7 1.4 



















Figure 1. Structure of compound 1 (2’,3’,4-trihydroxyl-3,5,4’-trimethoxyl 
bibenzyl, combretastatin B5). 
 
 
methoxy functions on one aromatic ring and dimethoxy-
hydroxy moieties on the second. The 1H-NMR spectra 
showed aromatic protons at 6.5 ppm (1H, d, J = 8.4 Hz) 
and 6.36 ppm (1H, d, J = 8.4 Hz) which are ortho coupled 
as well as the 2-proton singlet at 6.4 ppm. There is also a 
signal at 3.84 ppm integrating to three methoxyl groups 
and a complex multiplet at 2.82 ppm which is typical of 
the ethane bridge in bibenzylic compounds (Majumder et 
al., 1999; Katerere, 2001). By comparison with the 
literature and 2-D NMR, compound 1 was found to be 
2’,3’,4-trihydroxyl-3,5,4’-trimethoxyl bibenzyl 
(combretastatin B5). Though previously isolated from the 
seed of C. kraussi (Pellizzoni et al., 1992), this is the first 
report of its presence in plant leaves. 
Compound 1 had an in vitro antibacterial activity 
against   all   the   four   test   organisms   that   compared  
 
Figure 2. Solvent-solvent fractionation of 140 g of C. woodii. Quantity 
extracted in each fraction by group separation is indicated. 
 
 
favourably with ampicillin and chloramphenicol. S. aureus 
was the most sensitive of all the test organisms with an 
MIC value of 16 µg/ml followed by E. faecalis (125 µg/ml) 
and P. aeruginosa (125 µg/ml) and E. coli  (250 µg/ml)  
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Figure 3. Chromatogram and bioautogram of acetone extract of C. woodii leaves separated into different 
fractions by solvent-solvent extraction. TLC plate developed in EMW sprayed with vanillin-sulphuric acid [left] 
and with S. aureus culture incubated overnight and then sprayed with INT [right]. Growth inhibition indicated by 
clearing zones on TLC plate. Lanes from left to right: hexane (H), chloroform (CHCl3), carbon tetrachloride 
(CCl4), 35% water in methanol (35% w/m), butanol (B) and water (W) fractions. 
 
 
Table 2. MIC values in µg/ml of Combretastatin B5, ampicillin and chloramphenicol 
towards four pathogens. 
 
Bacteria Combretastatin B5 Ampicillin Chloramphenicol 
S. aureus 16 80 160 
E. coli >250 160 40 
P. aeruginosa 125 125 125 




against S. aureus with potential clinical application. 
Derivatives have been previously shown to possess 
potent anti-mitotic activity (Pellizzoni et al., 1992). There 
are no previous reports of its antibacterial activity.  
Combretastatin B5 had a relatively low activity against 
E. faecalis, although the chloroform fraction was three 
times more active against E. faecalis than against S. 
aureus (Table 2).  This can only be explained if other 
antibacterial compounds present in the chloroform extract 
had substantial activity against E. faecalis or if there were 
synergistic effects with other compounds that were 
removed on purification of combretastatin B5.  The MIC 
of the pure compound towards S. aureus was 16 g/ml.  
The MIC of the crude acetone extract was 310 g/ml. 
This represents a c. 20-fold increase in potency with 
purification. The crude extract represented 100 mg/g leaf 
powder.  From this it follows that, if there is only one 
antibacterial compound active towards S. aureus in the 
acetone extract, the concentration of combretastatin B5 
should be 100/20 i.e. c. 5 mg/g leaf powder.  With the 
inherent inaccuracy of the two-fold serial dilution assay 
there could be a doubling or halving of this value. Another 
way of roughly calculating the concentration in leaf 
material is to judge the concentration when 50 g of 
crude extract was separated by TLC. When we separated 
different masses of CB5 in the same volume (5 l), the 
size of the CB5 band in the crude extract was equivalent 
to c. 5 g of the pure compound. Because 50 g of the 
crude extract was chromatographed (5 l of 100 mg/ml), 
it means that the concentration was c. 100 x 5/50 i.e. c. 
10 mg/g. This very high concentration makes the use of 
extracts for clinical purposes a viable possibility 
particularly in poor communities. 
 
 
Summary of spectroscopic data 
 
2’,3’,4-trihydroxyl-3,5,4’-trimethoxyl bibenzyl (combreta-
tatin B5), C17H20O6 (1). Yellow amorphous solid; 
1H-NMR 
(300 MHz, CDCl3) 6.40 (2H, s), 6.54 (1H, d, J 8.4 ), 6.35, 
(1H, d, J 8.4), 3.84 (9H, s), 2.82 (2H, m) 13C-NMR  (75 






146.8 (C-3), 132.2 (C-4), 146.8 (C-5), 105.1 (C-6), 36.5 
(C-1a), 32.1 (C-1’a), 121.5 (C-1’), 142.1 (C-2’), 132.7 (C-
3’), 145.2 (C-4’), 102.3 (C-5’), 120.1 (C-6’), 56.2 (3,5- 
OMe),   56.1  (4’-OMe).   HREIMS m / z   (rel. int.):   320 
[M]+(41%), 153 [M-C9H11O3]






The leaves of C. woodii contain several antibacterial 
compounds of which the major compound active against 
S. aureus was isolated and characterized. This 
compound, though reported elsewhere previously, was 
isolated from the leaves of Combretum spp. for the first 
time and its potent antibacterial activity noted here for the 
first time.  Further work should be directed towards 
testing the toxicity of CB5, expanding the assay to other 
micro-organisms and possible pre-clinical development. 
The high concentration of this compound in leaves 
also make the use of leaf extracts a viable possibility. 
These results partly validate the ethnobotanical use of 
many Combretum species for conditions that may be of 
bacterial aetiology. C. woodii extracts also contain other 
antibacterial compounds with high antibacterial activity 
against Escherichia coli, Pseudomonas aeruginosa and 
Enterococcus faecalis (Eloff et al., 2005). This warrants 
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